1-4 of 4
Stavroula Kousteni, PhD
Close
Sort by
Journal Articles

Pharmacological Targeting of Osteoblast-Induced MDS and AML

Ioanna Mosialou, PhD, Marta Galan-Diez, PhD, Andrew Vandenberg, Abdullah Mahmood Ali, PhD, Azra Raza, MD, Stavroula Kousteni, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5235.
https://doi.org/10.1182/blood-2018-99-119985
Published: 2018
Journal Articles

Activation Levels of b-Catenin Signaling in Osteoblasts Define a Threshold for the Development of Myeloid Neoplasia of Variable Severity

Ioanna Mosialou, PhD, Alvaro Cuesta-Dominiguez, PhD, Govind Bhagat, MD, Ellin Berman, MD, Azra Raza, MD, Stavroula Kousteni, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2946.
https://doi.org/10.1182/blood.V130.Suppl_1.2946.2946
Published: 2017
Journal Articles

Hematopoietic Progenitors and Erythropoietin Affect Osteoblast Function and Lead to Osteoporosis in a Thalassemia Mouse Model

Zhiwei Yang, MD, PhD, Stefano Rivella, PhD, F Patrick Ross, PhD, Stavroula Kousteni, PhD, Maria G Vogiatzi, MD
Journal: Blood
Blood (2012) 120 (21): 3261.
https://doi.org/10.1182/blood.V120.21.3261.3261
Published: 2012
Journal Articles

Leukemogenic Transformation of Hematopoietic Cells by Constitutive Activation of Canonical Wnt Signaling in Osteoblast Precursors

Aruna Kode, Sanil Manavalan, Ioanna Mossialou, Govind Bhagat, MBBS, Murty Vundavalli, Ronald DePinho, Julie Teruya-Feldstein, MD, Ellin Berman, MD, Stavroula Kousteni, PhD
Journal: Blood
Blood (2012) 120 (21): 509.
https://doi.org/10.1182/blood.V120.21.509.509
Published: 2012